Life-extension therapy: Auranofin, a drug used in the treatment of  Rheumatoid arthritis,  inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 9/August/2017, 11.29 pm

Natural product-based therapy for anxiety and depression:  Magnolol, isolated from Houpu Magnolia and Magnolia Grandiflora (MG),  decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 9/August/2017, 12.54 am
August 8, 2017
Natural product-derived Lifespan extension therapy: Mangiferin, isolated from Mangoes,  prolongs mammalian life span via down regulation of angiotensin II type I receptor (AT1R), 9/August/2017, 11.37 pm
August 9, 2017
Show all

What they say:

A study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal protein S6 kinase 1 signaling regulates mammalian life span.” This study was published in the 2 October 2009 issue of the Journal “Science” (I.F: 31.477 ) by Prof Dominic J. Withers, Dr. Selman C and others.


What we say: 

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports, for the first time, that: Life-extension therapy: Auranofin, a drug used in the treatment of  Rheumatoid arthritis,  inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span


Research findings to Therapeutic opportunity: 

Figure 1. Mechanistic insight into how Auranofin may extend lifespan. Auranofin may promote longevity by suppressing the expression of p70 S6 kInase

Auranofin, by  increasing  the expression of its target gene, it may suppress Ribosomal protein S6 kinase 1 (p70S6 Kinase) expression. Thereby, it may promote: (1) resistance to bone, immune, and motor dysfunction; (2) insulin sensitivity; and (3) longevity (fig. 1).   

[easy_payment currency=”USD”]

Thus, pharmacological formulations encompassing “Auranofin or its analogs, either alone or in combination with any of the known longevity-promoting compound(s) may be used to extend the lifespan of an individual (fig. 1).


Details of the research findings: 

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic Information: How  Auranofin decreases the expression of p70 S6 Kinase and promotes mammalian life span

# Research cooperation

Amount: $100#

For purchase and payment information, you may reach us at info@genomediscovery.org


References:

CitationBoominathan, L.,    Life-extension therapy: Auranofin, a drug used in the treatment of  Rheumatoid arthritis,  inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 9/August/2017, 11.29 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or newbioideas.com/

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.